•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treat
More than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026
Applied Biomics Launches New Antigen Affinity Purified HCP Antibody with 95% Coverage
Critical Infrastructure Technologies Provides an Update to its Executed Letter of Intent with H. Cegielski - Poznan S.A.
Vercel Appoints Mitchell Hashimoto, Co-Founder of HashiCorp and Creator of Terraform, to Board of Directors
Critical Infrastructure Technologies Executes a Letter of Intent with H. Cegielski - Poznan S.A.
IBM Shares Rise After Jefferies Upgrade to Buy on AI Momentum
Vercel Appoints Susan St. Ledger, former President of Worldwide Field Operations at HashiCorp, to Board of Directors
HashiCorp Previews the Future of Agentic Infrastructure Automation with Project infragraph
HashiCorp Expands Unified Lifecycle Management for Hybrid Cloud Operations
Veeva Commercial Pulse Improves Segmentation and Targeting with Brick-Level HCP Access Data for 21 Countries
IBM closes $6.4B HashiCorp acquisition
IBM's $6.4B HashiCorp acquisition cleared by UK
UK competition watchdog clears IBM-HashiCorp $6.4 billion merger
HashiCorp to announce fourth quarter fiscal year 2025 financial results on March 6, 2025
New Strong Buy Stocks for January 29th
Here's Why HashiCorp, Inc. (HCP) is a Strong Momentum Stock
HashiCorp, Inc. (HCP) Hits Fresh High: Is There Still Room to Run?
Why HashiCorp, Inc. (HCP) is a Top Momentum Stock for the Long-Term
UK antitrust watchdog launches review of IBM's HashiCorp takeover